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Abstract 
Ototoxins inhibit the muscarinic receptor-activated inositol phosphate synthesis in the rat cochlea. In order to study this inhibitory 
mechanism, we investigated the effects of the ototoxins ethacrynate, cisplatin, HgCI2 and neomycin on [3H]quinuclidinyl benzylate 
binding to muscarinic receptors in adult and 12-day-old rat cochleas. The results are similar whatever the age: at concentrations 
that inhibit the inositol phosphate synthesis, ethacrynate is without effect. Neomycin only reduces [3H]quinuclidinyl benzylate binding 
at concentrations in the millimolar range. Cisplatin and HgCI2 block the binding in a dose-dependent way. These results suggest 
that the block of the transduction system by cisplatin and HgCI2 is due to direct interactions with muscarinic binding sites. Moreover, 
considering these data together with previous results, ethacrynate and neomycin may affect the phosphoinositide signalling pathway 
at targets including phosphoinositides and G proteins. 
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Ototoxins are molecules belonging to various classes 
(anti-cancer drugs, aminoglycoside antibiotics, mercuri- 
als, diuretics) that induce the loss of hearing and/or bal- 
ance. Ototoxicity poses therefore a severe limitation on 
the clinical use of some of these drugs [9]. In the cochlea, 
several ototoxins have been shown to interact with the 
polyphosphoinositide turnover [3,19]. Muscarinic recep- 
tor-activated inositol phosphate synthesis is specifically 
inhibited by ototoxins in the cochlea while the basal 
turnover is not sensitive to these drugs [3]. These findings 
were obtained in 12-day-old rat cochleas, a stage when 
the cochleas are extremely sensitive to aminoglycoside- 
induced ototoxicity [17]; and when the synthesis of the 
inositol phosphates, coupled to muscarinic receptors, is 
transiently enhanced [2]. These data suggest that ototox- 
ins reduce the activity of at least one of the main proteins 
in the polyphosphoinositide signalling pathway: i.e. mus- 
carinic receptor, G protein and phospholipase C. An- 
other alternative is the formation of a complex between 
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ototoxins and phosphoinositides which deprives phos- 
pholipase C of its phosphoinositide substrates [19]. 
Then, in order to shed more light on the mechanism(s) 
of the ototoxin-induced suppression of the carbachol- 
elicited formation of inositol phosphates, we assessed the 
effects of ototoxins on muscarinic receptors. This was 
achieved by investigating the effects of mercuric chloride, 
the diuretic ethacrynate, the anti-cancer drug cisplatin 
and the aminoglycoside neomycin on the binding of the 
antagonist quinuclidinyl benzylate (QNB) to muscarinic 
receptors [26], in membrane preparations of both adult 
and 12-day-old rat cochleas. 
Membrane preparation. Adult and 12-day-old Wistar 
rats were anesthetized by inhalation of halothane before 
decapitation. The cochleas were dissected from temporal 
bones and the stria vascularii were removed. The dis- 
sected cochleas, thus composed of the organ of Corti, the 
spiral ganglion and the peripheral part of the cochlear 
nerve contained in the bony modiolus, were collected in 
phosphate buffered saline, pH 7.4 (PBS; 50 mM 
Na2HPO4, 50 mM KH2PO4, 125 mM NaCI) at 0-4°C. 
Cochleas were washed 4 times with PBS and then ho- 
mogenized in PBS using an all glass homogenizer at the 
concentration of 12 cocbleas/ml. Following a centrifuga- 
tion at 300 x g for 10 min, the supernatant containing the 
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cochlear membranes was taken, and then stored at 
-70oc before use. 
Assays of [S H]quinuclidiny£ benzylate binding. Previ- 
ous studies demonstrated that membrane preparation 
concentrated from 6 to 10 cochleas/ml bind QNB linearly 
[4,24]. Thus, membranes were di'~uted in PBS at 6 coch- 
teaslml and aliquots (320 pl) were\ mixed with 40 pl PBS 
and [3H]QNB (New England Nuc~ar, Boston, MA; spe- 
cific activity: 45.4 Ci/mmol) at v~rious concentrations 
and incubated at 25°C for 90 min. ~'he binding reaction 
was stopped by filtration of the sarrtples onto Whatman 
GF/B filters and by washing the filters with 3 x 4 ml PBS 
at 0-4oc. The amount of [3H]QNB retained per filter was 
measured by liquid scintillation counting. This proce- 
dure allowed the determination of the total amount of 
bound QNB. In order to measure the non-specific bind- 
ing, 1 pM atropine (Sigma Chemical Co., St. Louis, MO) 
was added to the incubation medium. The amount of 
specifically bound QNB was obtained by subtracting 
non-specific binding from the total binding. Trials of 
displacement of bound QNB were conducted by adding 
the ototoxins to the medium. Here, it must be stressed 
that the ototoxins were used in concentration ranges at 
which they inhibit the phosphoinositide metabolism [3]. 
The results were normalized to the amount of protein 
present in the membrane preparation, which was meas- 
ured according to Lowry and coworkers [14]. 
Data expression and statistical analysis. The results 
were analyzed using the LIGAND computer program 
[15]. They were expressed either as ratios of the amount 
of bound QNB to the quantity of protein contained in 
the samples (fmol of QNB/mg of protein), or as percent- 
ages of the amount of specifically bound QNB. Data are 
means + S.E.M. of 3 experiments, at least. Each individ- 
ual experimetat was composed oe duplicated data points. 
The statistical significance of the data was determined 
using one-way ANOVA. 
Properties of the QNB binding. The saturation of the 
QNB binding was obtained by incubating membranes 
with increasing concentrations of QNB. Saturation 
curves (n = 6) were subjected to Scatchard analyses for 
both stages of development (Fig. I). The concentrations 
of binding sites (Bin,0 were 35 + 3 ( + S.E.M.) and 
43 + 5 fmol QNB/mg protein and the dissociation con- 
stants (Kd) were 42 + 4 and 30 + 1 pM for the 12-day- 
old and adult preparations, respectively. Both Hill coeffi- 
cients were close to unity (0.96 + 0.03 for 12-day-old 
membranes and 0.98 + 0.06 for adult preparation). 
Displacement of the QNB binding by ototoxins. In 12- 
day-old cochleas (Fig. 2, left), incubating the membranes 
with 0.08 nM of QNB resulted in a specific QNB binding 
of 30 + 7 fmol QNB/mg protein (+  SEM) in controls 
and it corresponded to 0.44 + 0.10 fmol QNB/cochlea. 
HgC12 caused a dose-dependent decrease in the QNB 
binding with an inhibition constant (Ki) of 4 + 14 pM. 
Cisplatin reduced the QNB binding in a dose-dependent 
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Fig. 1. Examples of Scatchard analysis the QNB binding in cochlear 
membranes from 12-day-old and adult rats. Membranes were incu- 
bated with increasing concentration of[3H]QNB until saturation of the 
binding and saturation curves obtained from duplicated data-points 
were then subjected to Scatchard analysis. Error bars are S.E.M. of the 
duplicated data and are not shown when they are smaller than the 
symbols. These experiments were replicated 6 times for each develop- 
mental stage and the means Bmax and Kd values obtained are given in 
the results. 
way with a Ki value of 493 _+ 55 pM. Neomycin partially 
inhibited the QNB binding at concentrations above 1 
raM; for instance it reduced the binding of 55 + 10% at 
10 mM (p < 0.01). Ethacrynate, at all tested concentra- 
tions, had no effect on the specific binding. 
In adult cochleas (Fig. 2, right), the specific QNB bind- 
ing was 25 + 6 fmol QNB/mg protein ( + S.E.M.) in con- 
trols and it corresponds to 0.47 + 0.11 fmol QNB/coch- 
lea. The effects of ototoxins were similar to those 
observed in the immature stage: HgCI2 and cisplatin 
supressed in a dose-dependent manner the QNB binding 
with Ki values of 31 + 8 and 220 + 16 pM, respectively. 
Neomycin at concentrations higher than 1 mM partially 
decreased the QNB binding (32 + 5% of inhibition at 15 
raM, P < 0.01). Ethacrynate was without effect on the 
QNB binding when applied at concentrations which 
blocks the inositol phosphate formation [3]. 
When comparing the data obtained at both stages of 
development, only cisplatin displaced QNB binding with 
a significant greater efficacy in the adult than in the 
immature preparation (P < 0.01). HgCI2 seems to reduce 
QNB binding more efficiently in immature than adult 
preparation. However, the difference in the Ki values is 
not statistically significant. 
The binding features of QNB to cochlear membranes 
are in line with the previous characterization of muscar- 
inic binding sites during the rat cochlear development [4]. 
Indeed, Kd and Bm,x values and Hill numbers are in the 
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Fig. 2. Effects of ototoxins on specific QNB binding to cochlear membranes of 12-day-old (left panel) and adult rats (right panel). Tritiated QNB 
was used at 0.08 nM. The data are means + S.E.M. of, at least, 3 determinations conducted in duplicate and are expressed as percentages of the level 
of specific bound QNB, taken as 100%. The 100% levels correspond to 30 + 7 and 25 + 6 fmol of QNBImg of protein for the immature and adult 
stages, respectively. 
range of the corresponding binding parameters estab- 
lished in the developmental study (in 12-day-old prepa- 
ration: Bmax = 39 + 2 fmol QNB/mg protein, Kd = 42 _+ 7 
pM and Hill number = 0.92 _+ 0.05; in adult prepration: 
Bmax = 42 -+ 3 fmol QNB/mg protein, Kd = 28 + 3 pM 
and Hill number = 0.97 + 0.02; [4]). When comparing 
the effects of ototoxins on the QNB binding and on the 
inositol phosphate formation, reported earlier [3], it ap- 
pears that cisplatin and HgCI2 reduce the QNB binding 
with efficacies that seem comparable to those of their 
inhibitions of the muscarinic receptor-activated inositol 
phosphate synthesis [3]. Therefore, a direct action on 
muscarinic binding sites may explain the block by cis- 
platin and HgCI2 of the inositol phosphate synthesis in 
the rat cochlea. 
In the peripheral auditory system, muscarinic recep- 
tors are of the M3 subtype [4,18] and are particularly 
present at the cholinergic synapses between medial effer- 
ent axons and outer hair cells [6,10]. They are also pre- 
sumably located at synapses between lateral efferent 
axons and afferent dendrites of auditory neurons [18]. 
These synapses are bathed by the perilymph that is likely 
to be the main route of ototoxins from the serum to 
target cells. Most pharmacokinetic surveys of ototoxins 
in the cochlea have been devoted to neomycin and other 
aminoglycosides [7,13,20,21,22,23]. In cochlear tissues, 
neomycin concentration was found not to exceed 100 
gM [7]. Perilymphatic level of aminoglycoside amounts 
to 10-20 gM in experiments using drugs at concentra- 
tions higher than therapeutic dosages; while therapeutic 
treatment yields to perilymphatic concentrations of 4--7 
/zM [20,21]. Perilymphatic levels measured in patients 
treated with aminoglycosides are close to 1 gM [13]. 
Therefore, it appears that the block of muscarinic bind- 
ing sites by neomycin may not play a toxic role since it 
only occurs at 10 mM and above. 
Ethacrynate and N-ethylmaleimide, a molecule that 
uncouples muscarinic signalling pathways [1,8,12,16,25], 
inhibit the muscarinic receptor-activated inositol phos- 
phate synthesis in an additive manner in the rat cochlea 
[5], suggesting that they act on the same targets. In addi- 
tion, N-ethylmaleimide affects neither the muscarinic re- 
ceptor binding nor t~,? basal metabolism of inositol 
phosphates [5] as doe:s ethacrynate. Therefore, eth- 
acrynate and N-ethylmaleimide block the signalling 
pathway in an identical fashion. Since N-ethylmaleimide 
has been shown to suppress muscarinic receptor-linked 
transduction systems by blocking G proteins in various 
models [1,8,12] and since ethacrynate seems to inhibit G 
proteins associated with adenylate cyclase in the cochlea 
[11], we propose that ethacrynate reduces the muscarinic 
receptor-activated inositol phosphate synthesis by block- 
ing the coupling function of G proteins. The ethacrynate- 
induced uncoupling may also affect regions of the mus- 
carinic receptor and the phospholipase C that are 
involved in interactions with the G protein. Moreover, 
ethacrynate may not act on the catalytic domain of phos- 
pholipase C since this drug does not affect the basal 
phosphoinositide metabolism [3]. 
In summary, the inhibition of the inositol phosphate 
turnover in the cochlea mediated by cisplatin and HgC12 
seems to be due to a block of muscarinic binding sites. 
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For neomycin and ethacrynate, which have no signifi- 
cant effect on the binding site, the inhibition of the 
inositol phosphate release should be accounted for by 
different mechanisms. Actually, aminoglycosides could 
interact directly with phosphoinositides [19] while eth- 
acrynate might inhibit the coupling mechanism of the 
signalling pathway. 
We thank Dr. Guy Richardson and Prof. Jochen 
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